A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2004
11/10/2004	EP0975660B1 COMPOUNDS AND METHODS FOR INHIBITING THE INTERACTION BETWEEN alpha-CATENIN and beta-CATENIN
11/10/2004	EP0975352A4 Protection of living systems from the adverse effects of stress
11/10/2004	EP0658206B1 Inhibitor resistant serine proteases
11/10/2004	CN1545552A Genes and proteins, and their uses
11/10/2004	CN1545551A Human monoclonal antibody against hepatitis C virus E2 glycoprotein
11/10/2004	CN1545521A Peptide as antagonist of VEGF receptor Flt-1
11/10/2004	CN1545424A Anti-cancer medicine comprising disintegrin genes and treating methods thereof
11/10/2004	CN1545422A Compositions and methods for enhanced pharmacological activity through oral and parenteral administration of compositions comprising polypeptide drug substances and other poorly absorbed active ingred
11/10/2004	CN1544637A Method for preparing mB7.1-GPI fusion proteins and their uses
11/10/2004	CN1544628A Trichina TS88 gene, their protein products and uses
11/10/2004	CN1544473A Recombinant fusion protein of mycobacterium tuberculosis Ag85B antigen and human IL-2, and its uses
11/10/2004	CN1544472A Branched polyethylene glycol-interferon and its making method and uses
11/10/2004	CN1544468A Polyethylene glycol-interferon connected with amido bond and its making method and uses
11/10/2004	CN1544465A Protein for promoting nerve differentiation and resisting cell death, and its coding gene
11/10/2004	CN1544464A Peptides
11/10/2004	CN1544463A Screening for liver cancer metastasis related protein molecule CK19 and its uses
11/10/2004	CN1544462A Heterologous expression of neisserial proteins
11/10/2004	CN1544461A Uro-genital condition treatment system
11/10/2004	CN1544092A Ophthalmic compositions containing galactomannan polymers and borate
11/10/2004	CN1544088A Immediate release tablet
11/10/2004	CN1544087A Application of antalzyme and gene recombinate antalzyme 134 pure products in the preparation of birds and livestock diseases treating medicine
11/10/2004	CN1544086A Application of apolipoprotein A-I in the preparing process for medicine capable of resisting endotoxin and inhibiting cytokine release
11/10/2004	CN1544085A Reproduction rate increasing preparation and its making method for cow and ewe
11/10/2004	CN1544084A Prolonged delivery of peptides
11/10/2004	CN1544083A Novel extract method for nutrient solution rich in protein polypeptide
11/10/2004	CN1544082A Hepatitis B resistant action of transfer factor
11/10/2004	CN1175109C Expression system for producing recombined human erythrogenin, method for purifying secreted human erythrogenin
11/10/2004	CN1175106C Human insulin recombinant gene, preparation method and application
11/10/2004	CN1175105C Purification of vitamin-K dependent proteins by membrane chromatography
11/10/2004	CN1175102C Preparation of alpha-1 antichymotrypsin
11/10/2004	CN1174998C Peptide immunogens for prevention and treatment of allergy
11/10/2004	CN1174997C Terminal blocked pentahelicoprotein and its use
11/10/2004	CN1174996C Inhibitor and stimulator of stem cell proliferation and use thereof
11/10/2004	CN1174993C VEGI, an inhibitor for angiogenesis and tumor growth
11/10/2004	CN1174774C Chinese medicine multienzyme emulsifying method
11/10/2004	CN1174753C Improved copolymer-1 composed of copolymers
11/10/2004	CN1174742C Controlled release of metal cation-stabilized interferon
11/10/2004	CN1174741C Surface modified particulate compositions of biologically active substances
11/09/2004	US6815540 Improved solubility/yield/ease of handling; fusion proteins; for diagnostics/drugs/research
11/09/2004	US6815534 Tissue plasminogen activator-like protease
11/09/2004	US6815533 For storage, handling, and recovery; prevents concentration gradients/autoproteolysis
11/09/2004	US6815531 For diagnosis/therapy of autoimmune diseases; antitumor agents; drugs; cytotoxic t-lymphocytes
11/09/2004	US6815441 Reaction products of taurultam and glucose
11/09/2004	US6815437 Virginiamycins as bactericides; pristinamycin chemical intermediates
11/09/2004	US6815431 Delivering a neurotrophic formulation comprising a neurotrophin encoding lentiviral expression vector, into one or more delivery sites within a region of the brain containing targeted neurons expressed for therapy of brain disorder
11/09/2004	US6815430 Gene expression base sequences for therapeutic use and drugs for gene therapy
11/09/2004	US6815427 Sericin-containing material, process for producing the same method of using the same
11/09/2004	US6815426 Angiogenesis-inhibitory tripeptides, compositions and their methods of use
11/09/2004	US6815425 Administered with n-tert-butyl- alpha -(2-sulfophenyl)nitrone (spbn); neuroprotectants
11/09/2004	US6815424 Intranasal administration of polypeptides in powdered form
11/09/2004	US6815422 Administering angiostatin
11/09/2004	US6815421 Obesity treatment using synthetic, protected polypeptide
11/09/2004	US6815420 Methods of using chemokine beta-6
11/09/2004	US6815419 Antiulcer agent
11/09/2004	US6815418 Administering transforming growth factor(tgf)-alpha polypeptides, related polypeptides, and mimetics thereof to stimulate proliferation of insulin producing cells
11/09/2004	US6815417 Administering to humans or animals stanniocalcin to inhibit differentiation and maturation of adipocytes
11/09/2004	US6815416 Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor
11/09/2004	US6815415 Diagnosis and treatment of malignant neoplasms
11/09/2004	US6815414 Pharmaceutical compositions for the treatment of helicobacter pylori-associated disorders
11/09/2004	US6815212 Methods and compositions for enhancing sensitivity in the analysis of biological-based assays
11/09/2004	US6815188 Human kinases and polynucleotides encoding the same
11/09/2004	US6815182 For diagnosis/therapy/prophyaxis of infections/diseases; vaccines; genetic engineering
11/09/2004	US6815171 Two-domain mhc polypeptides include mhc( major histocompatibility complex) class ii-based molecules that covalently linked beta 1 and alpha 1 domains, and mhc class i-based molecules that covalently linked alpha-1 and alpha-2
11/09/2004	US6815166 HIN-1, a tumor suppressor gene
11/09/2004	US6814983 Specific formulations of vitamins and minerals for supplementing those with high physiological stress levels such as during pregnancy and lactation
11/09/2004	US6814982 Suspension of an EPI-HNE protein, process of preparation thereof, dry powder aerosol derived therefrom, pharmaceutical compositions containing said suspension or aerosol, and their uses
11/09/2004	US6814981 Ganglioside immunostimulating complexes and uses thereof
11/09/2004	US6814969 Epitopes recognized by t-cells (cd-8/cd-4 antigens) derived from herpetic lesions; fusion proteins; antigen presenting cells; vaccines
11/09/2004	US6814967 Polypeptides
11/09/2004	US6814966 Monoclonal or polyclonal antibody which inhibits or antangonizes tnf- alpha, such as infliximab, thereby treating the subject with glaucoma
11/09/2004	US6814965 Methods of decreasing ZVEGF3 activity
11/09/2004	US6814964 Supramolecules containing binding and therapeutic molecules bound to hybridized nucleic acids
11/09/2004	US6814962 Defective recombinant adenovirus comprising a nucleic acid sequence coding for a biologically active human lipoprotein lipase
11/09/2004	CA2282360C Preparation of powder agglomerates
11/09/2004	CA2274596C Compositions and methods for enhancing intestinal function
11/09/2004	CA2273080C Mutants of the lag-3 proteins, products for the expression of these mutants and use
11/09/2004	CA2265824C Antifungal combination therapy
11/09/2004	CA2138137C Diphtheria toxin vaccines
11/09/2004	CA2109572C Method for reducing side-effects of a drug
11/09/2004	CA1341464C Hepatitis e, an enterically transmitted hepatitis viral agent
11/04/2004	WO2004095023A1 Novel method of screening
11/04/2004	WO2004094996A2 System and method for determining differential protein expression, diagnostic biomarker discovery system and method of using the same, and protein biomarkers and therapeutic and diagnostic uses thereof
11/04/2004	WO2004094991A2 Treatment or prevention of respiratory viral infections with alpha thymosin peptides
11/04/2004	WO2004094988A2 Tolerance to graft prior to thymic regeneration
11/04/2004	WO2004094673A2 Methods for monitoring drug activities in vivo
11/04/2004	WO2004094649A2 Tolerance to graft following thymic reactivation
11/04/2004	WO2004094648A2 Methods of treating diseases responsive to induction of apoptosis and screening assays
11/04/2004	WO2004094647A2 Methods of treating diseases responsive to induction of apoptosis and screening assays
11/04/2004	WO2004094641A2 A novel method of modulating bone-realted activity
11/04/2004	WO2004094637A1 Method of accumulating allergen-specific t cell antigen determinant in plant and plant having the antigen determinant accumulated therein
11/04/2004	WO2004094629A1 Human alkaline sphingomyelinase and use thereof
11/04/2004	WO2004094621A2 Polynucleotide encoding a novel trp channel family member, ltrpc3, and splice variants thereof
11/04/2004	WO2004094620A2 Truncated baff receptors
11/04/2004	WO2004094618A2 Modulation of diacylglycerol acyltransferase 1 expression
11/04/2004	WO2004094614A2 Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics
11/04/2004	WO2004094608A2 Human procolipase like nucleic acids and polypeptides and their methods of use threof
11/04/2004	WO2004094605A2 Methods and compositions for inhibiting stat signaling pathways
11/04/2004	WO2004094601A2 Methods of treating pin1 associated disorders by covalent modification of active site residues
11/04/2004	WO2004094599A2 Disease prevention and vaccination following thymic reactivation
11/04/2004	WO2004094590A2 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins

1 ... 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 1550 1551 1552 1553 1554 1555 1556 1557 1558 ... 3163